LLY - Lilly target price raised at Argus on Mounjaro Zepbound sales
2024-05-14 10:39:47 ET
More on Eli Lilly
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- Eli Lilly: Don't Overpay For Miracle Drugs
- Lilly could partner with Cipla to market GLP-1 drugs in India - report
- One in eight U.S. adults admits to GLP-1 usage as public awareness climbs